Labetalol infusion for refractory hypertension causing severe hypotension and bradycardia: an issue of patient safety, Patient Safety in Surgery
Por um escritor misterioso
Descrição
Incremental doses of intravenous labetalol are safe and effective and, at times, such therapy may need to be augmented by a continuous infusion of labetalol to control severe hypertension. Continuous infusions of labetalol may exceed the recommended maximum daily dose of 300 mg on occasion. We report a case in which hypertension occurring after an abdominal aortic aneurysm repair, initially responsive to intermittent intravenous beta-blockade, became resistant to this therapy leading to the choice of an intravenous labetalol infusion as the therapeutic option. The labetalol infusion resulted in a profound cardiovascular compromise in this postoperative critically ill patient. While infusions of labetalol have successfully been used, prolonged administration in the intensive care unit requires vigilance and the establishment of a therapeutic rationale/policy for interventions, such as the ready availability of glucagon, β-agonists, phosphodiesterase inhibitors, insulin, and vasopressin when severe cardiovascular depression occurs.
Links To And Excerpts From The IBCC Chapter, Hypertensive Emergency - Tom Wade MD
Catecholamine-induced hypertensive crises: current insights and management - The Lancet Diabetes & Endocrinology
Labetalol HCl
Hypertension in Pregnancy
Labetalol Tablets: Package Insert
Hemodynamic Safety of Continuous Infusion Labetalol Versus Esmolol Combination Therapies for Type B Aortic Dissections
Labetalol: Package Insert
IM 3 Flashcards
Nursing Diagnosis for Hypertension: 7 Nursing Care Plans [2023 Guide] - Nurseslabs
Comparison of the Effect of Two Different Doses of Labetalol to Induce Controlled Hypotension on Hemodynamic Changes During Spinal Fusion Surgery, Anesthesiology and Pain Medicine
Hypertensive emergency - EMCrit Project
de
por adulto (o preço varia de acordo com o tamanho do grupo)